We are live on ! Find out more
KURA icon

Kura Oncology
KURA

183 hedge funds and large institutions have $531M invested in Kura Oncology in 2025 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 62 increasing their positions, 57 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

9% more repeat investments, than reductions

Existing positions increased: 62 | Existing positions reduced: 57

3% less first-time investments, than exits

New positions opened: 35 | Existing positions closed: 36

7% less call options, than puts

Call options by funds: $596K | Put options by funds: $640K

1% less funds holding

Funds holding: 185 → 183 (-2)

1.74% less ownership

Funds ownership: 101.34% → 99.59% (-1.7%)

23% less capital invested

Capital invested by funds: $686M → $531M (-$155M)

Holders
183
Holders Change
-2
Holders Change %
-1.08%
% of All Funds
2.45%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
35
Increased
62
Reduced
57
Closed
36
Calls
$596K
Puts
$640K
Net Calls
-$44K
Net Calls Change
-$303K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$40.4M
2
SCM
Suvretta Capital Management
New York
+$18.4M
3
SI
Sofinnova Investments
California
+$6.17M
4
AC
Armistice Capital
New York
+$6.02M
5
PM
Prosight Management
Texas
+$5.87M

Top Sellers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
-$19.6M
2
SL
Siren LLC
Connecticut
-$11.7M
3
Morgan Stanley
Morgan Stanley
New York
-$10.5M
4
EC
EcoR1 Capital
California
-$7.15M
5
BNP Paribas Asset Management
BNP Paribas Asset Management
France
-$6.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
GT
201
Glenmede Trust
Pennsylvania
– -$166K -19,076 Closed
DFCM
202
Dark Forest Capital Management
Puerto Rico
– -$153K -17,538 Closed
Balyasny Asset Management
203
Balyasny Asset Management
Illinois
– -$144K -16,485 Closed
VF
204
Virtu Financial
New York
– -$139K -15,912 Closed
BG
205
Bellevue Group
Switzerland
– -$118K -13,600 Closed
OF
206
Optimize Financial
California
– -$99.7K -11,447 Closed
LCAM
207
Long Corridor Asset Management
Hong Kong
– -$87.1K -10,000 Closed
VEA
208
Virtus ETF Advisers
New York
– -$63.9K -7,336 Closed
RTC
209
Riverview Trust Company
Washington
– -$18.7K -2,151 Closed
RS
210
R Squared
Hong Kong
– -$14.1K -1,620 Closed
BIG
211
Brooklyn Investment Group
New York
– -$8.73K -1,002 Closed
RA
212
Rise Advisors
New York
– -$4.63K -531 Closed
PWMG
213
Private Wealth Management Group
New Jersey
– -$2.12K -243 Closed
PA
214
Parallel Advisors
California
– -$1.65K -212 Closed
ACM
215
Aster Capital Management
United Arab Emirates
– -$1.5K -172 Closed
WTA
216
Washington Trust Advisors
Massachusetts
– -$1K -115 Closed
PWA
217
Physician Wealth Advisors
Utah
– -$758 -87 Closed
IA
218
IFP Advisors
Florida
– -$78 -9 Closed
C
219
Covestor
United Kingdom
– +$62 +8 +133%
5 6 7 8
9

KURA Hedge Fund Activity: Q1 2025 in Review

183 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q1 2025, worth a combined $531M — down 23% from $686M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of KURA and 35 opened new positions — a net loss of 1 holder — while 57 trimmed existing stakes and 62 added.

The largest buyer was BVF Inc, adding an estimated $40.4M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $19.6M sold.

  • 183 institutional investors held Kura Oncology (KURA) as of Q1 2025, down from 185 in Q4 2024.
  • Funds reported $531M of Kura Oncology stock for Q1 2025, down 23% quarter-over-quarter.
  • 35 funds opened new Kura Oncology positions in Q1 2025 and 36 closed out, a net change of -1 holder.
  • The largest Kura Oncology buyer in Q1 2025 was BVF Inc, an estimated $40.4M added.
  • The largest Kura Oncology seller in Q1 2025 was Avoro Capital Advisors, an estimated $19.6M sold.

Based on aggregated 13F filings for Q1 2025.